Engineered immune cells aim to prevent leukemia relapse after transplant
NCT ID NCT06735690
First seen Nov 12, 2025 · Last updated May 24, 2026 · Updated 26 times
Summary
This early study tests whether giving special immune cells (CAR T cells) along with a vaccine can safely help prevent leukemia from coming back after a stem cell transplant. The CAR T cells are made from the donor's immune cells and are designed to attack a protein called CD19 found on leukemia cells. The vaccine helps boost the immune response. The trial involves 15 people with high-risk acute lymphoblastic leukemia and focuses on safety and feasibility.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.